CalciMedica
CALC
30 hedge funds and large institutions have $5.93M invested in CalciMedica in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 4 closing their positions.
233% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 3
0% more funds holding
Funds holding: 30 → 30 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
2.77% less ownership
Funds ownership: 29.44% → 26.67% (-2.8%)
21% less capital invested
Capital invested by funds: $7.49M → $5.93M (-$1.57M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Envestnet Asset Management
Chicago,
Illinois
|
+$59K |
| 2 |
1WA
180 Wealth Advisors
Federal Way,
Washington
|
+$58.5K |
| 3 |
SVWAG
Sound View Wealth Advisors Group
Savannah,
Georgia
|
+$34.5K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$28.8K |
| 5 |
WCG
Weaver Consulting Group
Huntington Beach,
California
|
+$23K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$485K |
| 2 |
PAM
PVG Asset Management
Golden,
Colorado
|
-$58K |
| 3 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$45K |
| 4 |
WIA
Wealthedge Investment Advisors
New York
|
-$35.7K |
| 5 |
BlackRock
New York
|
-$29.4K |
CALC Hedge Fund Activity: Q2 2025 in Review
30 of the 7,603 institutional investors tracked by Wall St. Rank reported a position in CalciMedica (CALC) for Q2 2025, worth a combined $5.93M — down 21% from $7.49M a quarter earlier.
Fund positioning in CALC was balanced in Q2 2025: 4 funds opened new positions, 4 closed out, 10 added to existing stakes and 3 trimmed.
The largest buyer was Envestnet Asset Management, adding an estimated $59K. The largest seller was Stonepine Capital Management, cutting an estimated $485K.
- 30 institutional investors held CalciMedica (CALC) as of Q2 2025, unchanged from Q1 2025.
- Funds reported $5.93M of CalciMedica stock for Q2 2025, down 21% quarter-over-quarter.
- 4 funds opened new CalciMedica positions in Q2 2025 and 4 closed out, a net change of 0 holders.
- The largest CalciMedica buyer in Q2 2025 was Envestnet Asset Management, an estimated $59K added.
- The largest CalciMedica seller in Q2 2025 was Stonepine Capital Management, an estimated $485K sold.
Based on aggregated 13F filings for Q2 2025.